ArticleCureus2024
Retrospective Audit of Transfusion Reactions in a Tertiary-Care Hospital in South India.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analysis of influencing factors for 5-year transfusion-related adverse events in a tertiary hospital using real-world data.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBlood transfusion is a double-edged sword, as it is a life-saving intervention but is also associated with various adverse reactions. However, blood transfusion safety can be improved by identifying these adverse reactions and taking appropriate interventions. Therefore, in this study, we aimed to determine the frequency and type of transfusion reactions occurring among in-patients at our hospital, as reported to our institute's blood center. MATERIALS AND
methodsThis cross-sectional study was carried out at the blood center of a tertiary-care hospital over three years and nine months from 2021 to 2024. During the study period, all transfusion reactions related to various blood and blood products reported to our blood center were recorded and analyzed according to departmental standard operating procedures.
resultsOut of 23,028 units of blood and blood products transfused during the study period, 105 (0.5%) cases of transfusion reaction were documented. The most common transfusion reaction reported was febrile non-hemolytic transfusion reaction (n=62; 59%), followed by allergic transfusion reaction (n=33; 31%), and 10 (10%) reported reactions were due to various other reasons.
conclusionThe relatively low incidence of transfusion reactions in this study (0.5%) may be due to our study's underreporting of transfusion reactions. This difference highlights the need to conduct continuous medical, educational programs for all healthcare professionals involved in the transfusion chain. Such programs should highlight the importance of documentation and reporting of adverse transfusion reactions so that hemovigilance systems can be established for improved patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.